GSK Counts On China, Product Innovation To Boost Consumer Product Sales
This article was originally published in The Tan Sheet
Executive Summary
GlaxoSmithKline recently launched its Sensodyne toothpaste line in China, its first new product there in more than 10 years
You may also be interested in...
Glaxo Consumer Finds Growth Groove Via Innovation, Acquisitions, Expansion
GlaxoSmithKline's consumer health care business appears back on track with 8 percent growth in the firm's latest earnings period, a year after it reported flat consumer sales hurt by the disappointing U.S. performance of weight-loss drug alli
GSK expands into Pakistan
The U.K. firm gains more than 30 pharmaceutical brands, including antibiotics, vitamins and dermatology products, in its purchase of Bristol-Myers Squibb Pakistan, GlaxoSmithKline announces Dec. 22. The $36.5 million acquisition "reinforces our commitment to Pakistan" and broadens GSK's product portfolio, says Abbas Hussain, president of emerging markets for GSK. The company says BMSP's 2007 sales were about $19 million and Pakistan's total pharmaceutical market is $1.2 billion. GSK's goal is to introduce old products in new places and coordinate its Rx and OTC segments in emerging markets (1"The Tan Sheet" Oct. 27, 2008, p. 14)
With Biotene Acquisition, Glaxo Tries Again In Dry Mouth Category
GlaxoSmithKline expands its consumer oral care business by acquiring Laclede's Biotene line of dry mouth products